Catalyst event

Alnylam Pharmaceuticals Inc (ALNY)

From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)

Alnylam is scheduled to host an RNAi Roundtable on zilebesiran and continuous blood-pressure control on September 17, 2026 at 10:30 a.m. ET.

Korean translation

Alnylam은 2026년 9월 17일 오전 10시 30분 ET에 지속적 혈압 조절을 주제로 zilebesiran RNAi Roundtable을 개최할 예정임.